AAAAAA

   
Results: 1-17 |
Results: 17
Comparison of the clinical validity of free prostate-specific antigen, alpha-1 antichymotrypsin-bound prostate-specific antigen and complexed prostate-specific antigen in prostate cancer diagnosis
Authors: Lein, M Jung, K Elgeti, U Petras, T Stephan, C Brux, B Sinha, P Winkelmann, B Schnorr, D Loening, SA
Citation: M. Lein et al., Comparison of the clinical validity of free prostate-specific antigen, alpha-1 antichymotrypsin-bound prostate-specific antigen and complexed prostate-specific antigen in prostate cancer diagnosis, EUR UROL, 39(1), 2001, pp. 57-64
A Multicenter Clinical Trial on the use of alpha(1)-antichymotrypsin-prostate-specific antigen in prostate cancer diagnosis
Authors: Lein, M Jung, K Hammerer, P Graefen, M Semjonow, A Stieber, P Ossendorf, M Luboldt, HJ Brux, B Stephan, C Schnorr, D Loening, SA
Citation: M. Lein et al., A Multicenter Clinical Trial on the use of alpha(1)-antichymotrypsin-prostate-specific antigen in prostate cancer diagnosis, PROSTATE, 47(2), 2001, pp. 77-84
Receiver-operating characteristic as a tool for evaluating the diagnostic performance of prostate-specific antigen and its molecular forms - What hasto be considered?
Authors: Jung, K Stephan, C Lein, M Brux, B Sinha, P Schnorr, D Loening, SA
Citation: K. Jung et al., Receiver-operating characteristic as a tool for evaluating the diagnostic performance of prostate-specific antigen and its molecular forms - What hasto be considered?, PROSTATE, 46(4), 2001, pp. 307-310
Molecular forms of prostate-specific antigen in serum with concentrations of total prostate-specific antigen < 4 mu g/L: Are they useful tools for early detection and screening of prostate cancer?
Authors: Jung, K Stephan, C Elgeti, U Lein, M Brux, B Kristiansen, G Rudolph, B Hauptmann, S Schnorr, D Loening, SA Sinha, P
Citation: K. Jung et al., Molecular forms of prostate-specific antigen in serum with concentrations of total prostate-specific antigen < 4 mu g/L: Are they useful tools for early detection and screening of prostate cancer?, INT J CANC, 93(5), 2001, pp. 759-765
Osteoprotegerin in serum as a novel marker of bone metastatic spread in prostate cancer
Authors: Jung, K Lein, M von Hosslin, K Brux, B Schnorr, D Loening, SA Sinha, P
Citation: K. Jung et al., Osteoprotegerin in serum as a novel marker of bone metastatic spread in prostate cancer, CLIN CHEM, 47(11), 2001, pp. 2061-2063
Elimination of serum complexed prostate-specific antigen after radical retropubic prostatectomy
Authors: Stephan, C Jung, K Brux, B Lein, M Sinha, P Schnorr, D Leoning, SA
Citation: C. Stephan et al., Elimination of serum complexed prostate-specific antigen after radical retropubic prostatectomy, CLIN CH L M, 38(4), 2000, pp. 309-311
Different stability of free and complexed prostate-specific antigen in serum in relation to specimen handling and storage conditions
Authors: Jung, K Lein, M Brux, B Sinha, P Schnorr, D Loening, SA
Citation: K. Jung et al., Different stability of free and complexed prostate-specific antigen in serum in relation to specimen handling and storage conditions, CLIN CH L M, 38(12), 2000, pp. 1271-1275
Ratio of alpha1-antichymotrypsin - Prostate specific antigen to total prostate specific antigen in prostate cancer diagnosis
Authors: Lein, M Jung, K Elgeti, U Brux, B Sinha, P Schnorr, D Loening, SA
Citation: M. Lein et al., Ratio of alpha1-antichymotrypsin - Prostate specific antigen to total prostate specific antigen in prostate cancer diagnosis, ANTICANC R, 20(6D), 2000, pp. 4997-5001
ACT-PSA and complexed PSA elimination kinetics in serum after radical retropubic prostatectomy: Proof of new complex forming of PSA after release into circulation
Authors: Stephan, C Jung, K Brux, B Lein, M Sinha, P Schnorr, D Loening, SA
Citation: C. Stephan et al., ACT-PSA and complexed PSA elimination kinetics in serum after radical retropubic prostatectomy: Proof of new complex forming of PSA after release into circulation, UROLOGY, 55(4), 2000, pp. 560-563
Molecular forms of prostate-specific antigen in malignant and benign prostatic tissue: Biochemical and diagnostic implications
Authors: Jung, K Brux, B Lein, M Rudolph, B Kristiansen, G Hauptmann, S Schnorr, D Loening, SA Sinha, P
Citation: K. Jung et al., Molecular forms of prostate-specific antigen in malignant and benign prostatic tissue: Biochemical and diagnostic implications, CLIN CHEM, 46(1), 2000, pp. 47-54
Ratio of free or complexed prostate-specific antigen (PSA) to total PSA: Which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer?
Authors: Jung, K Elgeti, U Lein, M Brux, B Sinha, P Rudolph, B Hauptmann, S Schnorr, D Loening, SA
Citation: K. Jung et al., Ratio of free or complexed prostate-specific antigen (PSA) to total PSA: Which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer?, CLIN CHEM, 46(1), 2000, pp. 55-62
Determination of alpha(1)-antichymotrypsin-PSA complex in serum does not improve the differentiation between benign prostatic hyperplasia and prostate cancer compared with total PSA and percent free PSA
Authors: Jung, K Brux, B Lein, M Knabich, A Sinha, P Rudolph, B Schnorr, D Loening, SA
Citation: K. Jung et al., Determination of alpha(1)-antichymotrypsin-PSA complex in serum does not improve the differentiation between benign prostatic hyperplasia and prostate cancer compared with total PSA and percent free PSA, UROLOGY, 53(6), 1999, pp. 1160-1167
Determination of alpha(1)-antichymotrypsin-PSA complex in serum does not improve the differentiation between benign prostatic hyperplasia and prostate cancer compared with total PSA and percent free PSA - Reply
Authors: Jung, K Brux, B Lein, M Sinha, P Schnorr, D Loening, SA
Citation: K. Jung et al., Determination of alpha(1)-antichymotrypsin-PSA complex in serum does not improve the differentiation between benign prostatic hyperplasia and prostate cancer compared with total PSA and percent free PSA - Reply, UROLOGY, 53(6), 1999, pp. 1168-1168
Rapid detection of elevated prostate-specific antigen levels in blood: Performance of various membrane strip tests compared
Authors: Jung, K Zachow, J Lein, M Brux, B Sinha, P Lenk, S Schnorr, D Loening, SA
Citation: K. Jung et al., Rapid detection of elevated prostate-specific antigen levels in blood: Performance of various membrane strip tests compared, UROLOGY, 53(1), 1999, pp. 155-160
Free and complexed prostate specific antigen in the differentiation of benign prostatic hyperplasia and prostate cancer: Studies in serum and plasma samples
Authors: Lein, M Jung, K Brux, B Knabich, A Sinha, P Schnorr, D Loening, SA
Citation: M. Lein et al., Free and complexed prostate specific antigen in the differentiation of benign prostatic hyperplasia and prostate cancer: Studies in serum and plasma samples, J UROL, 162(2), 1999, pp. 502-502
A gap between total prostate-specific antigen and the sum of free prostate-specific antigen plus alpha(1)-antichymotrypsin-prostate-specific antigen in patients with prostate carcinoma but not in those with benign prostate hyperplasia
Authors: Jung, K Brux, B Knabich, A Lein, M Sinha, P Schnorr, D Loening, SA
Citation: K. Jung et al., A gap between total prostate-specific antigen and the sum of free prostate-specific antigen plus alpha(1)-antichymotrypsin-prostate-specific antigen in patients with prostate carcinoma but not in those with benign prostate hyperplasia, CLIN CHEM, 45(3), 1999, pp. 422-424
Complexed prostate-specific antigen and the "prostate-specific antigen gap" - Reply
Authors: Jung, K Brux, B Sinha, P Lein, M Schnorr, D Loening, SA
Citation: K. Jung et al., Complexed prostate-specific antigen and the "prostate-specific antigen gap" - Reply, CLIN CHEM, 45(11), 1999, pp. 2040-2041
Risultati: 1-17 |